Genotoxicity Assessment Services
Overview
Genotoxicity assessment is a cornerstone of in vitro safety pharmacology, designed to evaluate the potential of compounds to damage genetic material, either directly (DNA damage) or indirectly (interference with repair mechanisms or chromosomal stability). These assessments are essential in identifying risks such as mutagenesis, carcinogenesis, or reproductive toxicity, providing critical data for drug development, chemical safety evaluation, and regulatory submissions.
Genotoxicity assessment services at Creative Biolabs encompass a comprehensive range of assays that detect DNA damage, assess chromosomal alterations, and investigate the mechanisms underlying genotoxic effects. By combining standard regulatory tests with cutting-edge mechanistic and high-throughput methods, the service ensures reliable and actionable insights into compound safety.
Integrated Genotoxicity Assays and Mechanistic Insights
To provide robust and holistic analysis, Creative Biolabs integrates core genotoxicity tests with advanced mechanistic assays into a streamlined workflow. This approach not only identifies genotoxic risks but also uncovers the underlying biological mechanisms.
-
Mutagenicity and DNA Damage Detection
-
Ames test
Detects point mutations or frame-shift mutations in bacteria. Metabolic activation ensures relevance to in vivo conditions. -
Comet assay
Measures DNA strand breaks in single cells, identifying early-stage DNA damage with high sensitivity. -
γ-H2AX assay
Quantifies phosphorylated H2AX protein as a marker of double-strand DNA breaks. Utilizes immunofluorescence or flow cytometry for visualization and quantification.
-
Ames test
-
Chromosomal Alterations and Aneuploidy
-
Chromosome aberration test
Evaluates structural changes and numerical abnormalities in chromosomes using mammalian cell lines. Results provide critical insights into clastogenic potential. -
Micronucleus assay
Detects small, extranuclear chromatin bodies (micronuclei) indicative of chromosomal damage or spindle apparatus interference. Applicable to both in vitro and in vivo systems.
-
Chromosome aberration test
-
Oxidative DNA Damage
- Measures oxidative DNA damage induced by reactive oxygen species (ROS). ELISA or mass spectrometry is employed to quantify the biomarker 8-oxo-2'-deoxyguanosine.
- DNA Damage Response (DDR) Analysis
To create a comprehensive genotoxicity assessment service that integrates the advanced components of DDR Analysis, we can expand the DDR section to include targeted assays, protein engineering, cell-based and biochemical approaches, and in vivo evaluations.
DDR analysis focuses on evaluating the mechanisms by which cells detect, signal, and repair DNA damage. By integrating a diverse range of DDR-specific tools and assays, this service offers in-depth insights into compound effects on genomic stability.
- Identify compounds that modulate DDR.
- High-throughput screening for activators or inhibitors.
- Expression and engineering of DDR-related proteins for functional studies.
- Biochemical and structural analysis.
- Enzyme activity assays.
- Electrophoretic Mobility Shift Assays (EMSA)
- Reporter Gene Assays: Tracks activation of DDR pathways in live cells.
- Synthetic Lethality Studies
- Gene-modified cell lines with DDR gene knockouts or pathway-specific reporters.
- Tailored cell models for studying DDR modulation.
- Protein-protein and protein-DNA interaction studies.
- Structural studies
- Validating DDR modulation in preclinical models.
- Biomarker analysis in animal tissues to assess compound effects.
To ensure a comprehensive evaluation of DNA damage and repair, Creative Biolabs integrates these DDR assays with genotoxicity testing in a seamless workflow:
a) In vitro screening: Initial evaluation using high-throughput DDR-targeting and cell-based assays.
b) Mechanistic studies: Biochemical, biophysical, and protein engineering approaches to elucidate mechanisms.
c) In vivo validation: Translational studies to confirm DDR modulation in preclinical models.
Advantages of Our Genotoxicity Assessment Services
Comprehensive Assay Portfolio
Integrates standard genotoxicity assays with advanced DDR analysis, covering molecular, cellular, and in vivo levels.
Mechanistic Insights
Combines DDR targeting, protein engineering, biochemical, biophysical assays to uncover the mechanisms behind DNA damage and repair.
Innovative Technologies
Incorporates gene editing, high-throughput screening, high-content imaging, and structural biology for cutting-edge research.
Customized Solutions
Tailored assay workflows to fit compound types, development stages, and client-specific requirements.
Applications
-
Drug Development
Assessing genotoxic risks of new drug candidates.
Identifying DDR-targeting compounds for cancer therapies. -
Cosmetic Testing
Ensuring the safety of cosmetic products and ingredients to meet regulatory standards globally. -
Mechanistic Research
Investigating DNA damage and repair pathways.
Studying synthetic lethality mechanisms for targeted therapies. -
Biological Therapeutics
Testing the genotoxicity of novel biologics and gene-editing tools.
Understanding off-target effects and DDR pathway interactions.
At Creative Biolabs, we understand the critical importance of assessing genotoxicity with precision and depth. If you're ready to take the next step in ensuring the safety and success of your compounds, we invite you to partner with us. Contact Creative Biolabs today to discuss how our genotoxicity assessment services can accelerate your research and development goals.
Download our brochure